Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Terminalia arjuna bark extract is a botanical extract derived from the stem bark of the *Terminalia arjuna* tree, a staple of Ayurvedic medicine. It is primarily utilized for its cardioprotective properties in conditions such as chronic heart failure, angina pectoris, hypertension, and dyslipidemia. The extract is a complex mixture of bioactive phytochemicals, including triterpenoids (arjunic acid, arjunetin, arjungenin), flavonoids, polyphenols, tannins, and glycosides. Its pharmacological profile is multi-targeted, exhibiting inotropic, anti-ischemic, antioxidant, antiplatelet, and hypolipidemic effects. While not developed by a single pharmaceutical entity, it has been extensively studied in clinical trials by various research institutions, particularly in the Indian subcontinent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Terminalia arjuna bark extract.